Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Cardiac Structure Injury After Radiotherapy for Breast Cancer: Cross-Sectional Study With Individual Patient Data.

Taylor C. et al, (2018), J Clin Oncol, 36, 2288 - 2296

Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer.

Boekel NB. et al, (2018), Br J Cancer, 119, 408 - 418

Cardiac Radiation Dose Reconstruction in the Study of Late Effects: A Comparison of Different Methods

Ntentas G. et al, (2018), RADIOTHERAPY AND ONCOLOGY, 127, S1091 - S1092

Metal artefact reduction for accurate tumour delineation in radiotherapy.

Kovacs DG. et al, (2018), Radiother Oncol, 126, 479 - 486

Risk factors for upgrading and upstaging of pre-operative biopsies in ductal carcinoma in situ

Mannu GS. et al, (2018), CANCER RESEARCH, 78

Exposure of the lungs in breast cancer radiotherapy: A systematic review of lung doses published 2010-2015.

Aznar MC. et al, (2018), Radiother Oncol, 126, 148 - 154

Risk stratification of childhood cancer survivors necessary for evidence-based clinical long-term follow-up.

Frobisher C. et al, (2017), Br J Cancer, 117, 1723 - 1731

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.

Pan H. et al, (2017), N Engl J Med, 377, 1836 - 1846

Life years lost attributable to late effects after radiotherapy for early stage Hodgkin lymphoma: The impact of proton therapy and/or deep inspiration breath hold.

Rechner LA. et al, (2017), Radiother Oncol, 125, 41 - 47

"To clip or not to clip. That is no question!".

Aznar MC. et al, (2017), Eur J Surg Oncol, 43, 1145 - 1147

A modeling study of functional magnetic resonance imaging to individualize target definition of seminal vesicles for external beam radiotherapy.

Damkjær S. et al, (2017), Acta Oncol, 56, 799 - 805

Making progress in early breast cancer: Taking time or accepting risk?

Mannu GS. and Dodwell D., (2017), Eur J Cancer, 78, 24 - 27

Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data.

Holyoake DLP. et al, (2017), Radiother Oncol, 123, 431 - 437

Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials.

Taylor C. et al, (2017), J Clin Oncol, 35, 1641 - 1649

Long-term hospitalisation rates among 5-year survivors of Hodgkin lymphoma in adolescence or young adulthood: A nationwide cohort study.

Rugbjerg K. et al, (2017), Int J Cancer, 140, 2232 - 2245

Risk of heart disease in relation to radiotherapy and chemotherapy with anthracyclines among 19,464 breast cancer patients in Denmark, 1977-2005.

Rehammar JC. et al, (2017), Radiother Oncol, 123, 299 - 305

Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines.

van Nimwegen FA. et al, (2017), Blood, 129, 2257 - 2265

Risk of Cerebrovascular Events in 178 962 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age: The TYACSS (Teenage and Young Adult Cancer Survivor Study).

Bright CJ. et al, (2017), Circulation, 135, 1194 - 1210

Population-Based Long-Term Cardiac-Specific Mortality Among 34 489 Five-Year Survivors of Childhood Cancer in Great Britain.

Fidler MM. et al, (2017), Circulation, 135, 951 - 963

A cardiac contouring atlas for radiotherapy.

Duane F. et al, (2017), Radiother Oncol, 122, 416 - 422

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?